{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:32:43Z","timestamp":1774611163903,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.pop.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T09:53:46Z","timestamp":1600854826000},"page":"691-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Renal Repercussions of Medications"],"prefix":"10.1016","volume":"47","author":[{"given":"Rachel","family":"Shaddock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine Vogel","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Beyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2020.08.006_bib1","series-title":"Pharmacotherapy","first-page":"871","article-title":"Drug-induced kidney disease","author":"Nolin","year":"2005"},{"key":"10.1016\/j.pop.2020.08.006_bib2","first-page":"538","article-title":"The epidemiology of acute renal failure in the world","volume":"12","author":"Uchino","year":"2006","journal-title":"Curr Opin Crit Care"},{"issue":"6","key":"10.1016\/j.pop.2020.08.006_bib3","first-page":"550","article-title":"Drug-induced acute kidney injury: diverse mechanisms of tubular injury","volume":"25","author":"Perazella","year":"2019","journal-title":"Curr Opin Crit Care"},{"issue":"12","key":"10.1016\/j.pop.2020.08.006_bib4","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind common drug nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.pop.2020.08.006_bib5","first-page":"1","article-title":"Frequency and predictors of polypharmacy in us medicare patients: a cross-sectional analysis at the patient and physician levels","volume":"29","author":"Ellenbogen","year":"2019","journal-title":"Drugs & aging"},{"key":"10.1016\/j.pop.2020.08.006_bib6","first-page":"27","article-title":"Avoidable costs in US healthcare: the $200 billion opportunity from using medicines more responsibly","author":"Aitken","year":"2013","journal-title":"IMS Institute for Healthcare Informatics"},{"issue":"6","key":"10.1016\/j.pop.2020.08.006_bib7","first-page":"743","article-title":"Drug-induced nephrotoxicity","volume":"78","author":"Naughton","year":"2008","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.pop.2020.08.006_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003088-199835010-00004","article-title":"Pharmacokinetic and pharmacodynamic changes in the elderly","volume":"35","author":"H\u00e4mmerlein","year":"1998","journal-title":"Clin Pharm"},{"issue":"5","key":"10.1016\/j.pop.2020.08.006_bib9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/jac\/dks030","article-title":"Acute kidney injury associated with trimethoprim\/sulfamethoxazole","volume":"67","author":"Fraser","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.pop.2020.08.006_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0002-9343(99)00041-8","article-title":"Crystal-induced acute renal failure","volume":"106","author":"Perazella","year":"1999","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.pop.2020.08.006_bib11","first-page":"57","article-title":"Drug-induced renal disorders","volume":"4","author":"Shahrbaf","year":"2015","journal-title":"J\u00a0Renal Inj Prev"},{"issue":"9","key":"10.1016\/j.pop.2020.08.006_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00228-014-1712-z","article-title":"Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention","volume":"70","author":"Jafari","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.pop.2020.08.006_bib13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/QAD.0000000000002223","article-title":"Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials","volume":"33","author":"Gupta","year":"2019","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.pop.2020.08.006_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.admecli.2004.10.001","article-title":"Nephrotoxicity of over-the-counter analgesics, natural medicines, and illicit drugs","volume":"16","author":"Blowey","year":"2005","journal-title":"Adolesc Med Clin"},{"key":"10.1016\/j.pop.2020.08.006_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2004.12.005","article-title":"Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population","volume":"45","author":"Huerta","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pop.2020.08.006_bib16","series-title":"Chronic kidney disease in the United States, 2019","year":"2019"},{"key":"10.1016\/j.pop.2020.08.006_bib17","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/00005344-200605001-00007","article-title":"COX-2 and the kidney","volume":"47","author":"Harris","year":"2006","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"10","key":"10.1016\/j.pop.2020.08.006_bib18","first-page":"1487","article-title":"Drug dosing adjustments in patients with chronic kidney disease","volume":"75","author":"Munar","year":"2007","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.pop.2020.08.006_bib19","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1016\/j.pop.2020.08.006_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jash.2010.03.001","article-title":"Combination therapy in hypertension","volume":"4","author":"Gradman","year":"2010","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.pop.2020.08.006_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ki.1991.43","article-title":"Diuretics","volume":"39","author":"Rose","year":"1991","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.pop.2020.08.006_bib22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3109\/0886022X.2014.917560","article-title":"Diuretics associated acute kidney injury: clinical and pathological analysis","volume":"36","author":"Wu","year":"2014","journal-title":"Ren Fail"},{"issue":"3","key":"10.1016\/j.pop.2020.08.006_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2165\/00002018-199615030-00005","article-title":"ACE inhibitors and the kidney","volume":"15","author":"Navis","year":"1996","journal-title":"Drug Saf"},{"key":"10.1016\/j.pop.2020.08.006_bib24","first-page":"337","article-title":"KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"2","year":"2012","journal-title":"Kidney inter, Suppl"},{"issue":"3","key":"10.1016\/j.pop.2020.08.006_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2020.08.006_bib26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/01.ASN.0000051594.21922.99","article-title":"Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study","volume":"14","author":"Mann","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.pop.2020.08.006_bib27","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.pop.2020.08.006_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/cc13897","article-title":"Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review","volume":"18","author":"Petejova","year":"2014","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.pop.2020.08.006_bib29","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/pds.1287","article-title":"Risk factors for statin-associated rhabdomyolysis","volume":"16","author":"Schech","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.pop.2020.08.006_bib30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2020.08.006_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ni1429","article-title":"T\u00a0cell-directed therapies: lessons learned and future prospects","volume":"8","author":"Liu","year":"2007","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.pop.2020.08.006_bib32","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI116440","article-title":"Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles","volume":"91","author":"Lanese","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.pop.2020.08.006_bib33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.pop.2020.08.006_bib34","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00007890-199302000-00014","article-title":"Diltiazem in renal allograft recipients receiving cyclosporine","volume":"55","author":"Chrysostomou","year":"1993","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.pop.2020.08.006_bib35","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/jgh.13737","article-title":"\"proton pump inhibitors: risks of long-term use.\"","volume":"32","author":"Eusebi","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.pop.2020.08.006_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2369-14-150","article-title":"Proton pump inhibitors and acute kidney injury: a nested case\u2013control study","volume":"14","author":"Klepser","year":"2013","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.pop.2020.08.006_bib37","doi-asserted-by":"crossref","first-page":"E166","DOI":"10.9778\/cmajo.20140074","article-title":"Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study","volume":"3","author":"Antoniou","year":"2015","journal-title":"CMAJ Open"},{"key":"10.1016\/j.pop.2020.08.006_bib38","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/ki.2014.74","article-title":"A\u00a0nationwide nested case\u2013control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use","volume":"86","author":"Blank","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.pop.2020.08.006_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/kisup.2012.77","article-title":"Summary of recommendation statements","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1016\/j.pop.2020.08.006_bib40","first-page":"40","article-title":"Assessing the risks and benefits of herbal medicine: an overview of scientific evidence","volume":"5","author":"Barrett","year":"1999","journal-title":"Altern Ther Health Med"},{"issue":"1","key":"10.1016\/j.pop.2020.08.006_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/j.ajkd.2004.02.009","article-title":"Herbs and the kidney","volume":"44","author":"Bagnis","year":"2004","journal-title":"Am J kidney Dis"},{"key":"10.1016\/j.pop.2020.08.006_bib42","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJM199903113401017","article-title":"Interstitial nephritis in a patient taking creatine","volume":"340","author":"Koshy","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"5 Suppl","key":"10.1016\/j.pop.2020.08.006_bib43","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1097\/00005768-199805001-01336","article-title":"Renal insufficiency after creatine supplementation in a college football athlete","volume":"30","author":"Kuehl","year":"1998","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"10.1016\/j.pop.2020.08.006_bib44","first-page":"555","article-title":"Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers","volume":"172","author":"Massey","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.pop.2020.08.006_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/advances\/nmy016","article-title":"Caffeine in kidney stone disease: risk or benefit?","volume":"9","author":"Peerapen","year":"2018","journal-title":"Adv Nutr"},{"issue":"6","key":"10.1016\/j.pop.2020.08.006_bib46","first-page":"1","article-title":"Dietary reference intakes: water, potassium, sodium, chloride, and sulfate","volume":"30","author":"Campbell","year":"2004","journal-title":"Clinical Nutrition Insight"},{"issue":"2","key":"10.1016\/j.pop.2020.08.006_bib47","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy","volume":"141","author":"Witt","year":"2012","journal-title":"Chest"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454320300609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454320300609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:44:27Z","timestamp":1758815067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454320300609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0095454320300609"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2020.08.006","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Repercussions of Medications","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}